In the UK, drug safety experts are advising women to discontinue weight-loss injections like Wegovy and Mounjaro if they are trying to conceive, pregnant, or breastfeeding. Although this caution is mentioned in patient leaflets, there are concerns that many women are not using these medications safely. For instance, Natasha Major experienced an unexpected pregnancy while on Mounjaro, raising worries about the impact on fetal development. Regulators emphasize that these GLP-1 drugs, primarily prescribed for obesity and diabetes management, should only be used under specific medical circumstances.
Drug safety experts in the UK warn women using weight-loss jabs should stop if trying for a baby, pregnant or breastfeeding, citing unknown risks to unborn babies.
Natasha Major, who became unexpectedly pregnant while using Mounjaro, expressed concern for her baby's safety and highlights potential misuse of weight-loss drugs among women.
Experts warn that the increasing popularity of 'skinny jabs' raises concerns over safe usage and proper medical guidance, as the drugs are intended for specific medical criteria.
The UK drugs regulator stresses that popular GLP-1 medications, such as Wegovy and Mounjaro, are meant for weight management under strict eligibility but are frequently misused.
Collection
[
|
...
]